Bristol Myers Squibb Co. Non-TR
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Bristol Myers Squibb Co. Non-TR in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Public Employees Retirement System of Ohio ($2) and GAMMA Investing LLC ($0).
- Company
- Bristol Myers Squibb Co. Non-TR
- Filed as
- CONTRA MIRATI THERAPEU NPV from 60468T105 (Q2 2024)
- CUSIP
- 604CVR027
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Public Employees Retirement System of Ohio | 0.00% | No change | 22,908 | $2 |
| GAMMA Investing LLC | 0.00% | No change | 223 | $0 |
"% of holder's portfolio" is BRISTOL MYERS SQUIBB CO NON-TR's weight in each manager's 13F, not the share of Bristol Myers Squibb Co. Non-TR the manager owns.